Related Experiment Video
Updated: Jun 17, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
[High altitude and preexisting lung diseases].
Laure Brossard1, Christophe Brossard, Pierre-Yves Jayet
1Service de médecine interne, Hôpital du Jura, 2800 Delémont.
Revue Medicale Suisse
|January 8, 2010
Summary
High altitude travel can pose risks for individuals with lung diseases. This paper offers guidance for general practitioners to help patients with pre-existing lung conditions safely enjoy high altitude environments.
Area of Science:
- Pulmonary Medicine
- Environmental Physiology
- Clinical Practice
Context:
- Increasing number of patients with lung diseases travel to high altitudes.
- Challenges in providing adequate medical advice for high-altitude travel to these patients.
- Need for evidence-based recommendations for managing pre-existing lung conditions at high altitudes.
Purpose:
- To review the physiological effects of high altitude on individuals with pre-existing lung diseases.
- To provide practical recommendations for general practitioners counseling these patients.
- To optimize the safety and well-being of patients with lung diseases during high-altitude sojourns.
Summary:
- High altitude exposure can exacerbate symptoms in patients with lung diseases.
- Understanding the physiopathology is crucial for risk assessment.
- Recommendations focus on patient selection, acclimatization, and medical management.
Impact:
- Improved patient counseling and management strategies for high-altitude travel.
- Enhanced safety for individuals with lung diseases visiting high-altitude resorts.
- Reduced risk of pulmonary complications associated with high altitude exposure.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...